Literature DB >> 20351172

The UBXN1 protein associates with autoubiquitinated forms of the BRCA1 tumor suppressor and inhibits its enzymatic function.

Foon Wu-Baer1, Thomas Ludwig, Richard Baer.   

Abstract

Although the BRCA1 tumor suppressor has been implicated in many cellular processes, the biochemical mechanisms by which it influences these diverse pathways are poorly understood. The only known enzymatic function of BRCA1 is the E3 ubiquitin ligase activity mediated by its highly conserved RING domain. In vivo, BRCA1 associates with the BARD1 polypeptide to form a heterodimeric BRCA1/BARD1 complex that catalyzes autoubiquitination of BRCA1 and trans ubiquitination of other protein substrates. In most cases, BRCA1-dependent ubiquitination generates polyubiquitin chains bearing an unconventional K6 linkage that does not appear to target proteins for proteasomal degradation. Since ubiquitin-dependent processes are usually mediated by cellular receptors with ubiquitin-binding motifs, we screened for proteins that specifically bind autoubiquitinated BRCA1. Here we report that the UBXN1 polypeptide, which contains a ubiquitin-associated (UBA) motif, recognizes autoubiquitinated BRCA1. This occurs through a bipartite interaction in which the UBA domain of UBXN1 binds K6-linked polyubiquitin chains conjugated to BRCA1 while the C-terminal sequences of UBXN1 bind the BRCA1/BARD1 heterodimer in a ubiquitin-independent fashion. Significantly, the E3 ligase activity of BRCA1/BARD1 is dramatically reduced in the presence of UBXN1, suggesting that UBXN1 regulates the enzymatic function of BRCA1 in a manner that is dependent on its ubiquitination status.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20351172      PMCID: PMC2876507          DOI: 10.1128/MCB.01056-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

1.  Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase.

Authors:  Angus Chen; Frida E Kleiman; James L Manley; Toru Ouchi; Zhen-Qiang Pan
Journal:  J Biol Chem       Date:  2002-04-01       Impact factor: 5.157

2.  BRCA1/BARD1 inhibition of mRNA 3' processing involves targeted degradation of RNA polymerase II.

Authors:  Frida E Kleiman; Foon Wu-Baer; Danae Fonseca; Syuzo Kaneko; Richard Baer; James L Manley
Journal:  Genes Dev       Date:  2005-05-15       Impact factor: 11.361

3.  Identification of a RING protein that can interact in vivo with the BRCA1 gene product.

Authors:  L C Wu; Z W Wang; J T Tsan; M A Spillman; A Phung; X L Xu; M C Yang; L Y Hwang; A M Bowcock; R Baer
Journal:  Nat Genet       Date:  1996-12       Impact factor: 38.330

4.  p62 mutations, ubiquitin recognition and Paget's disease of bone.

Authors:  R Layfield; J R Cavey; D Najat; J Long; P W Sheppard; S H Ralston; M S Searle
Journal:  Biochem Soc Trans       Date:  2006-11       Impact factor: 5.407

5.  Functional communication between endogenous BRCA1 and its partner, BARD1, during Xenopus laevis development.

Authors:  V Joukov; J Chen; E A Fox; J B Green; D M Livingston
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

6.  A novel protein specifically interacting with Homer2 regulates ubiquitin-proteasome systems.

Authors:  Takamasa Ishibashi; Sachie Ogawa; Yasuko Hashiguchi; Yuriko Inoue; Hiroshi Udo; Hiroshi Ohzono; Akihiko Kato; Reiko Minakami; Hiroyuki Sugiyama
Journal:  J Biochem       Date:  2005-05       Impact factor: 3.387

7.  The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression.

Authors:  Reena Shakya; Matthias Szabolcs; Ellen McCarthy; Elson Ospina; Katia Basso; Subhadra Nandula; Vundavalli Murty; Richard Baer; Thomas Ludwig
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-28       Impact factor: 11.205

8.  IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis.

Authors:  Mads Gyrd-Hansen; Maurice Darding; Maria Miasari; Massimo M Santoro; Lars Zender; Wen Xue; Tencho Tenev; Paula C A da Fonseca; Marketa Zvelebil; Janusz M Bujnicki; Scott Lowe; John Silke; Pascal Meier
Journal:  Nat Cell Biol       Date:  2008-10-19       Impact factor: 28.824

9.  Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation.

Authors:  Simin Rahighi; Fumiyo Ikeda; Masato Kawasaki; Masato Akutsu; Nobuhiro Suzuki; Ryuichi Kato; Tobias Kensche; Tamami Uejima; Stuart Bloor; David Komander; Felix Randow; Soichi Wakatsuki; Ivan Dikic
Journal:  Cell       Date:  2009-03-20       Impact factor: 41.582

10.  The ubiquitin E3 ligase activity of BRCA1 and its biological functions.

Authors:  Wenwen Wu; Ayaka Koike; Takashi Takeshita; Tomohiko Ohta
Journal:  Cell Div       Date:  2008-01-07       Impact factor: 5.130

View more
  31 in total

Review 1.  Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system.

Authors:  Bram Stynen; Hélène Tournu; Jan Tavernier; Patrick Van Dijck
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  The UBX protein SAKS1 negatively regulates endoplasmic reticulum-associated degradation and p97-dependent degradation.

Authors:  David P LaLonde; Anthony Bretscher
Journal:  J Biol Chem       Date:  2010-12-06       Impact factor: 5.157

3.  Ubiquitin-associated domain-containing ubiquitin regulatory X (UBX) protein UBXN1 is a negative regulator of nuclear factor κB (NF-κB) signaling.

Authors:  Yu-Bo Wang; Bo Tan; Rui Mu; Yan Chang; Min Wu; Hai-Qing Tu; Yu-Cheng Zhang; Sai-Sai Guo; Xuan-He Qin; Tao Li; Wei-Hua Li; Ai-Ling Li; Xue-Min Zhang; Hui-Yan Li
Journal:  J Biol Chem       Date:  2015-02-13       Impact factor: 5.157

4.  Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

Authors:  Jan B Heidelberger; Andrea Voigt; Marina E Borisova; Giuseppe Petrosino; Stefanie Ruf; Sebastian A Wagner; Petra Beli
Journal:  EMBO Rep       Date:  2018-02-21       Impact factor: 8.807

5.  Linkage via K27 Bestows Ubiquitin Chains with Unique Properties among Polyubiquitins.

Authors:  Carlos A Castañeda; Emma K Dixon; Olivier Walker; Apurva Chaturvedi; Mark A Nakasone; Joseph E Curtis; Megan R Reed; Susan Krueger; T Ashton Cropp; David Fushman
Journal:  Structure       Date:  2016-02-11       Impact factor: 5.006

6.  Linkage-specific conformational ensembles of non-canonical polyubiquitin chains.

Authors:  Carlos A Castañeda; Apurva Chaturvedi; Christina M Camara; Joseph E Curtis; Susan Krueger; David Fushman
Journal:  Phys Chem Chem Phys       Date:  2016-02-17       Impact factor: 3.676

Review 7.  Unraveling the complexity of ubiquitin signaling.

Authors:  Eric R Strieter; David A Korasick
Journal:  ACS Chem Biol       Date:  2012-01-11       Impact factor: 5.100

8.  Novel protein interactions with endoglin and activin receptor-like kinase 1: potential role in vascular networks.

Authors:  Guoxiong Xu; Miriam Barrios-Rodiles; Mirjana Jerkic; Andrei L Turinsky; Robert Nadon; Sonia Vera; Despina Voulgaraki; Jeffrey L Wrana; Mourad Toporsian; Michelle Letarte
Journal:  Mol Cell Proteomics       Date:  2013-12-07       Impact factor: 5.911

9.  Substitution of aspartic acid with glutamic acid at position 67 of the BRCA1 RING domain retains ubiquitin ligase activity and zinc(II) binding with a reduced transition temperature.

Authors:  Apichart Atipairin; Bhutorn Canyuk; Adisorn Ratanaphan
Journal:  J Biol Inorg Chem       Date:  2010-10-22       Impact factor: 3.358

10.  BRCA1 targets G2/M cell cycle proteins for ubiquitination and proteasomal degradation.

Authors:  S Shabbeer; D Omer; D Berneman; O Weitzman; A Alpaugh; A Pietraszkiewicz; S Metsuyanim; A Shainskaya; M Z Papa; R I Yarden
Journal:  Oncogene       Date:  2012-12-17       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.